In vivo, PLD1 deficiency resulted in loss of ROS production in the lung following lipopolysaccharide (LPS) challenge, and significantly attenuated deep vein thrombosis (DVT), a NET-associated pathology. The gene discussed is PLD1; the disease is deep vein thrombosis.